A comparative study between spinal drug ropivacaine versus bupivacaine in planed surgery under spinal anaesthesia
Not Applicable
- Conditions
- Health Condition 1: 4- Measurement and Monitoring
- Registration Number
- CTRI/2022/08/044660
- Lead Sponsor
- GCS Medical College hospital and researah centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with informed consent
Age between 18 to 75 Years
BMI <30kg/m2
ASA I & II
Infra umbilical Surgery <3 hours
Exclusion Criteria
Patient who will not give consent
BMI >30kg/m2
ASA III & IV
Contraindication to spinal anaesthesia
Known Allergy to Ropivacaine or any other local Anaesthetic Agent
Duration of Surgery > 3hours
Patients on chronic Anticoagulation or Antiplatelet drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess between Ropivacaine and Bupivacaine which has less cardiac and neurological complicationTimepoint: immediate after giving spinal anaesthesia
- Secondary Outcome Measures
Name Time Method To assess the Hemodynamics parameters and the regression of motor and sensory effects between ropivacaine and bupivacaineTimepoint: After 4 hours of giving spinal anaesthesia